First Page | Document Content | |
---|---|---|
Anisina’s History of Community Support Novogen’s lead anti-tropomyosin (ATM) drug candidate, Anisina, is in the unusual position of having a history of strong community support throughout its development. The anti-trAdd to Reading ListSource URL: www.novogen.comDownload Document from Source WebsiteFile Size: 449,00 KBShare Document on Facebook |